EXAGEN INC. Cash and Restricted Cash
EXAGEN INC. (XGN) had Cash and Restricted Cash of $24.79 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-04
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $24.79M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $21.71M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $32.42M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $35.85M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $24.79M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $21.71M 10-Q · filed 2026-05-11 |
| 2025-12-31 | $32.42M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $35.85M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $30.23M 10-Q · filed 2026-08-04 |
| 2025-03-31 | $11.39M 10-Q · filed 2026-05-11 |
| 2024-12-31 | $22.24M 10-Q · filed 2026-08-04 |
| 2024-09-30 | $22.23M 10-Q · filed 2025-11-04 |
| 2024-06-30 | $24.68M 10-Q · filed 2025-07-29 |
| 2024-03-31 | $27.47M 10-Q · filed 2025-05-05 |
| 2023-12-31 | $36.69M 10-K · filed 2026-03-10 |
| 2023-09-30 | $28.65M 10-Q · filed 2024-11-12 |
| 2023-06-30 | $31.67M 10-Q · filed 2024-08-05 |
| 2023-03-31 | $52.38M 10-Q · filed 2024-05-13 |
| 2022-12-31 | $62.59M 10-K · filed 2025-03-11 |
| 2022-09-30 | $68.90M 10-Q · filed 2023-11-13 |
| 2022-06-30 | $76.49M 10-Q · filed 2023-08-07 |
| 2022-03-31 | $89.85M 10-Q · filed 2023-05-15 |
| 2021-12-31 | $99.54M 10-K · filed 2024-03-18 |
| 2021-09-30 | $106.87M 10-Q · filed 2022-11-21 |
| 2021-06-30 | $112.68M 10-Q/A · filed 2022-11-21 |
| 2021-03-31 | $118.15M 10-Q · filed 2022-05-11 |
| 2020-12-31 | $57.55M 10-K · filed 2023-03-20 |
| 2020-09-30 | $61.53M 10-Q · filed 2021-11-10 |
| 2020-06-30 | $63.80M 10-Q · filed 2021-08-09 |
| 2020-03-31 | $68.75M 10-Q · filed 2021-05-11 |
| 2019-12-31 | $72.18M 10-K · filed 2022-03-22 |
| 2019-09-30 | $77.93M 10-Q · filed 2020-11-10 |
| 2019-06-30 | $16.34M 10-Q · filed 2020-07-28 |
| 2019-03-31 | $14.43M 10-Q · filed 2020-05-11 |
| 2018-12-31 | $13.26M 10-K · filed 2021-03-16 |
| 2018-09-30 | $5.48M 10-Q · filed 2019-11-12 |
| 2017-12-31 | $11.34M 10-K · filed 2020-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |